Title: Pain - Identifying and Commercializing First-in-Class Innovation - PowerPoint PPT Presentation

Description: The active pain pipeline is populated by 796 products across all stages of development, which exhibit a highly diverse range of molecular targets. The Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree of innovation. This is in stark contrast to the pain therapeutics market, which has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established active pharmaceutical ingredients and the concomitant mechanisms of action. – PowerPoint PPT presentation